Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: May 28, 2022

West-ward Pharms Int Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for WEST-WARD PHARMS INT, and what generic and branded alternatives to WEST-WARD PHARMS INT drugs are available?

WEST-WARD PHARMS INT has thirty-seven approved drugs.

There is one tentative approval on WEST-WARD PHARMS INT drugs.

Summary for West-ward Pharms Int

US Patents:	0
Tradenames:	34
Ingredients:	31
NDAs:	37

Drugs and US Patents for West-ward Pharms Int

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign up for a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
West-ward Pharms Int	DIPHENHYDRAMINE HYDROCHLORIDE	diphenhydramine hydrochloride	INJECTABLE;INJECTION	080817-002	Approved Prior to Jan 1, 1982	AP	RX	Yes	Yes		See Plans and Pricing				See Plans and Pricing
West-ward Pharms Int	FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	fluconazole	INJECTABLE;INJECTION	078107-002	Jul 30, 2008	AP	RX	No	No		See Plans and Pricing				See Plans and Pricing
West-ward Pharms Int	OCTREOTIDE ACETATE	octreotide acetate	INJECTABLE;INJECTION	076330-002	Apr 8, 2005	AP	RX	No	Yes		See Plans and Pricing				See Plans and Pricing
West-ward Pharms Int	MEPERIDINE HYDROCHLORIDE	meperidine hydrochloride	INJECTABLE;INJECTION	080455-007	Approved Prior to Jan 1, 1982	AP	RX	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca

Colorcon

Moodys

Boehringer Ingelheim

McKinsey

Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.